Department of Surgery Northwestern University Feinberg School of Medicine Chicago IL.
Department of Chemistry University of Chicago IL.
J Am Heart Assoc. 2020 Mar 3;9(5):e013496. doi: 10.1161/JAHA.119.013496. Epub 2020 Feb 24.
Background The potential role of the gut microbiome in cardiovascular diseases is increasingly evident. Arterial restenosis attributable to neointimal hyperplasia after cardiovascular procedures such as balloon angioplasty, stenting, and bypass surgery is a common cause of treatment failure, yet whether gut microbiota participate in the development of neointimal hyperplasia remains largely unknown. Methods and Results We performed fecal microbial transplantation from conventionally raised male C57BL/6 mice to age-, sex-, and strain-matched germ-free mice. Five weeks after inoculation, all mice underwent unilateral carotid ligation. Neointimal hyperplasia development was quantified after 4 weeks. Conventionally raised and germ-free cohorts served as comparison groups. Conclusions Germ-free mice have significantly attenuated neointimal hyperplasia development compared with conventionally raised mice. The arterial remodeling response is restored by fecal transplantation. Our results describe a causative role of gut microbiota in contributing to the pathogenesis of neointimal hyperplasia.
肠道微生物组在心血管疾病中的潜在作用日益明显。心血管手术后(如球囊血管成形术、支架置入术和旁路手术)导致的动脉再狭窄是治疗失败的常见原因,但肠道微生物群是否参与新生内膜增生的发生尚不清楚。
我们从常规饲养的雄性 C57BL/6 小鼠进行粪便微生物移植到年龄、性别和品系匹配的无菌小鼠。接种后 5 周,所有小鼠均进行单侧颈总动脉结扎。4 周后定量检测新生内膜增生。常规饲养和无菌两组作为对照。
与常规饲养的小鼠相比,无菌小鼠的新生内膜增生明显减轻。粪便移植恢复了动脉重塑反应。我们的研究结果描述了肠道微生物群在促进新生内膜增生发病机制中的因果作用。